| Thomas Wright, DPM | |
|
1125 W Kagy Blvd Ste 101, Bozeman, MT 59715-5879 | |
| (406) 586-5318 | |
| Not Available |
| Full Name | Thomas Wright |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 9 Years |
| Location | 1125 W Kagy Blvd Ste 101, Bozeman, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154704377 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 76502 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bozeman Health Deaconess Hospital | Bozeman, MT | Hospital |
| Livingston Healthcare | Livingston, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bozeman Podiatric Clinic Inc | 6507947652 | 2 |
News Archive
Diamond has announced that USA-based global biotechnology company Vertex Pharmaceuticals Incorporated is the first industrial user at the UK's world class new research facility, Diamond Light Source
Marcadia Biotech Inc. today announced that it has initiated a Phase 1 clinical trial of MAR701, a novel dual agonist of the incretin hormone receptors for glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Marcadia plans to initially develop this compound as a treatment for type 2 diabetes with once-weekly dosing. The Phase 1 trial will evaluate MAR701 in healthy volunteers at escalating dose levels.
In a pair of stories, Politico takes a look at how decisions made by governors in two very different states are playing.
Scientists at Columbia's Zuckerman Institute have contributed to solving a paradox of perception, literally upending models of how the brain constructs interpretations of the outside world. When observing a scene, the brain first processes details - spots, lines and simple shapes - and uses that information to build internal representations of more complex objects, like cars and people.
› Verified 3 days ago
| Provider Name | Bozeman Podiatric Clinic Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1144404401 PECOS PAC ID: 6507947652 Enrollment ID: O20080115000693 |
News Archive
Diamond has announced that USA-based global biotechnology company Vertex Pharmaceuticals Incorporated is the first industrial user at the UK's world class new research facility, Diamond Light Source
Marcadia Biotech Inc. today announced that it has initiated a Phase 1 clinical trial of MAR701, a novel dual agonist of the incretin hormone receptors for glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Marcadia plans to initially develop this compound as a treatment for type 2 diabetes with once-weekly dosing. The Phase 1 trial will evaluate MAR701 in healthy volunteers at escalating dose levels.
In a pair of stories, Politico takes a look at how decisions made by governors in two very different states are playing.
Scientists at Columbia's Zuckerman Institute have contributed to solving a paradox of perception, literally upending models of how the brain constructs interpretations of the outside world. When observing a scene, the brain first processes details - spots, lines and simple shapes - and uses that information to build internal representations of more complex objects, like cars and people.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Wright, DPM 1125 W Kagy Blvd Ste 101, Bozeman, MT 59715-5879 Ph: (406) 586-5318 | Thomas Wright, DPM 1125 W Kagy Blvd Ste 101, Bozeman, MT 59715-5879 Ph: (406) 586-5318 |
News Archive
Diamond has announced that USA-based global biotechnology company Vertex Pharmaceuticals Incorporated is the first industrial user at the UK's world class new research facility, Diamond Light Source
Marcadia Biotech Inc. today announced that it has initiated a Phase 1 clinical trial of MAR701, a novel dual agonist of the incretin hormone receptors for glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Marcadia plans to initially develop this compound as a treatment for type 2 diabetes with once-weekly dosing. The Phase 1 trial will evaluate MAR701 in healthy volunteers at escalating dose levels.
In a pair of stories, Politico takes a look at how decisions made by governors in two very different states are playing.
Scientists at Columbia's Zuckerman Institute have contributed to solving a paradox of perception, literally upending models of how the brain constructs interpretations of the outside world. When observing a scene, the brain first processes details - spots, lines and simple shapes - and uses that information to build internal representations of more complex objects, like cars and people.
› Verified 3 days ago
Bozeman Podiatric Clinic Inc Podiatrist Medicare: Medicare Enrolled Practice Location: 300 N Willson Ave Ste 801h, Bozeman, MT 59715 Phone: 406-586-5318 Fax: 406-586-1635 | |
Mr. Tod Russell Storm, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 931 Highland Blvd, Suite 3310, Bozeman, MT 59715 Phone: 406-587-8478 Fax: 406-582-0730 | |
Mr. Jan Dean Clark, DMD Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 300 No Willson, 602f, Bozeman, MT 59715 Phone: 406-586-5318 Fax: 406-586-1635 | |
Andrew H Rice, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3901 Wellness Way, Bozeman, MT 59718 Phone: 406-898-1200 | |
Dr. Casey Clarice Ebert, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 931 Highland Blvd, Suite 3310, Bozeman, MT 59715 Phone: 406-587-8478 | |
Dr. William Mann Wilshire Iv, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 931 Highland Blvd, Suite 3310, Bozeman, MT 59715 Phone: 406-587-8478 Fax: 406-582-0730 |